ZA925521B - Aminocarboxylate ligands having substituted aromatic amide moieties - Google Patents

Aminocarboxylate ligands having substituted aromatic amide moieties

Info

Publication number
ZA925521B
ZA925521B ZA925521A ZA925521A ZA925521B ZA 925521 B ZA925521 B ZA 925521B ZA 925521 A ZA925521 A ZA 925521A ZA 925521 A ZA925521 A ZA 925521A ZA 925521 B ZA925521 B ZA 925521B
Authority
ZA
South Africa
Prior art keywords
substituted aromatic
aromatic amide
amide moieties
aminocarboxylate ligands
aminocarboxylate
Prior art date
Application number
ZA925521A
Other languages
English (en)
Inventor
Radhakrishna Pillai
Pillai Radhakrishna
Edmund R Marinelli
R Marinelli Edmund
Ramachandran S Ranganathan
S Ranganathan Ramachandran
Michael F Tweedle
F Tweedle Michael
Sang-Ihn Kang
Kang Sang-Ihn
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of ZA925521B publication Critical patent/ZA925521B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0482—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group chelates from cyclic ligands, e.g. DOTA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Hydrogenated Pyridines (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
ZA925521A 1991-08-01 1992-07-22 Aminocarboxylate ligands having substituted aromatic amide moieties ZA925521B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73899891A 1991-08-01 1991-08-01

Publications (1)

Publication Number Publication Date
ZA925521B true ZA925521B (en) 1993-04-28

Family

ID=24970389

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA925521A ZA925521B (en) 1991-08-01 1992-07-22 Aminocarboxylate ligands having substituted aromatic amide moieties

Country Status (17)

Country Link
EP (1) EP0543482B1 (fr)
JP (1) JP2538165B2 (fr)
KR (1) KR930003911A (fr)
CN (1) CN1069027A (fr)
AT (1) ATE212861T1 (fr)
AU (1) AU2061592A (fr)
CA (1) CA2074867A1 (fr)
DE (1) DE69232408T2 (fr)
ES (1) ES2173862T3 (fr)
FI (1) FI923470A (fr)
HU (1) HUT62906A (fr)
IL (1) IL102570A0 (fr)
MX (1) MX9204434A (fr)
NO (1) NO305126B1 (fr)
PL (1) PL295490A1 (fr)
TW (1) TW213864B (fr)
ZA (1) ZA925521B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5310535A (en) * 1992-04-24 1994-05-10 The Dow Chemical Company Carboxamide modified polyamine chelators and radioactive complexes thereof for conjugation to antibodies
WO1995027705A1 (fr) * 1994-04-08 1995-10-19 Bracco International B.V. Composes amides aromatiques et leurs chelates metalliques
TW319763B (fr) 1995-02-01 1997-11-11 Epix Medical Inc
US6515113B2 (en) * 1999-02-18 2003-02-04 The Regents Of The University Of California Phthalamide lanthanide complexes for use as luminescent markers
FR2802928B1 (fr) * 1999-12-22 2003-01-31 Air Liquide Polyazacycloalcanes eventuellement greffes sur une matrice solide, complexes organometalliques les incorporant comme ligands. utilisation desdits composes a l'extraction de metaux lourds
AU2001277488B2 (en) * 2000-05-12 2006-05-18 University Hospital Prochelators of radiometal labeled molecules
FR2827515B1 (fr) * 2001-07-20 2005-06-03 Oreal Composition moussante a base de silice et de polymere cationique
US20090238768A1 (en) * 2005-12-02 2009-09-24 Oskar Axelsson Multimeric magnetic resonance contrast agents
EP2774611A4 (fr) * 2011-10-06 2015-03-04 Ihi Corp Composition magnétique et procédé de production associé
CN103073667B (zh) * 2013-01-25 2016-05-11 南京大学 一种双伯胺基螯合树脂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03203282A (ja) * 1989-12-29 1991-09-04 Nec Kansai Ltd 半導体レーザダイオード
JP2776953B2 (ja) * 1990-04-10 1998-07-16 日本メジフィジックス株式会社 多官能性金属キレート化合物とその用途
DE4035760A1 (de) * 1990-11-08 1992-05-14 Schering Ag Mono-n-substituierte 1,4,7,10-tetraazacyclododecan-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
JP2807852B2 (ja) * 1991-07-18 1998-10-08 株式会社ミドリ十字 新規キレート化剤、該キレート化剤と金属原子との錯化合物及びそれを含む診断剤

Also Published As

Publication number Publication date
HUT62906A (en) 1993-06-28
JP2538165B2 (ja) 1996-09-25
FI923470A (fi) 1993-02-02
DE69232408D1 (de) 2002-03-21
ES2173862T3 (es) 2002-11-01
ATE212861T1 (de) 2002-02-15
FI923470A0 (fi) 1992-07-31
KR930003911A (ko) 1993-03-22
TW213864B (fr) 1993-10-01
DE69232408T2 (de) 2002-09-19
JPH05208920A (ja) 1993-08-20
EP0543482A1 (fr) 1993-05-26
CN1069027A (zh) 1993-02-17
NO923038D0 (no) 1992-07-31
MX9204434A (es) 1994-06-30
NO305126B1 (no) 1999-04-06
HU9202513D0 (en) 1992-10-28
PL295490A1 (en) 1993-05-31
NO923038L (no) 1993-02-02
IL102570A0 (en) 1993-01-14
AU2061592A (en) 1993-02-04
EP0543482B1 (fr) 2002-02-06
CA2074867A1 (fr) 1993-02-02

Similar Documents

Publication Publication Date Title
ZA928739B (en) Organic salts of N,N'-diacetyl cystine.
DE3476540D1 (en) Quinoline antibacterial compounds
FR04C0014I2 (fr)
IL109658A0 (en) Herbicides
TW267927B (fr)
NZ330023A (en) Fused pyrrolecarboxanilides and their use as a GABA brain receptor ligands
GR3025715T3 (en) Azolylamine derivative
AU635603B2 (en) Polymers containing halomethyl-1,3,5-triazine moieties
ZA925521B (en) Aminocarboxylate ligands having substituted aromatic amide moieties
IL99106A0 (en) Novel tricyclic compound or salts thereof,method for producing the same and antimicrobial agent containing the same
DE69818261D1 (en) Hydroxycyclopentanone
TW231256B (fr)
EP0495450A3 (en) Polyamine phenols as radioprotective agents
ZA942125B (en) Herbicidal heterocyclic compounds.
EP0721957A4 (fr) Compose ge3
EP0659752A4 (fr)
EP0994111A4 (fr) Derives de tetrahydrofuranne
PL320904A1 (en) Novel compounds, 3,6-diamino-10-methyl-9,10-dihydroacridinic salts
ZA9110058B (en) Novel compounds.
PL317908A1 (en) Novel compound: 3,6-diamino 10-methyl-9,10-dihydroacridine
ZA957307B (en) Oxa- or thia-aliphatically bridged quinoxaline-2,3-diones